Envoy Medical, Inc.
COCH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $27 | $23 | $102 | $99 |
| - Cash | $5 | $4 | $0 | $1 |
| + Debt | $20 | $1 | $35 | $23 |
| Enterprise Value | $41 | $19 | $136 | $121 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -28.8% | 33.3% | -23.5% | – |
| Gross Profit | -$1 | -$0 | -$0 | -$0 |
| % Margin | -229.8% | -149.7% | -110.1% | -148.1% |
| EBITDA | -$20 | -$30 | -$9 | -$7 |
| % Margin | -8,802.7% | -9,426.9% | -3,641.8% | -2,193.5% |
| Net Income | -$21 | -$30 | -$16 | -$9 |
| % Margin | -9,242.2% | -9,469% | -6,718.6% | -2,798.4% |
| EPS Diluted | -1.49 | -2.54 | -1.57 | -1.05 |
| % Growth | 41.3% | -61.8% | -49.5% | – |
| Operating Cash Flow | -$18 | -$17 | -$9 | -$7 |
| Capital Expenditures | -$1 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$19 | -$17 | -$9 | -$7 |